USE FIRST20 TO GET 20% OFF ON YOUR FIRST ORDER
✓
What is it?
This is a two-peptide research blend that acts on two separate pathways to stimulate the body’s own growth hormone release. Using both together produces a stronger response than either compound alone.
—
Key Benefits (from research)
– Boosts growth hormone release – Activating two different receptor systems at once creates a larger growth hormone pulse than a single compound can.
– Works with your body’s natural rhythms – Research shows the body continues to release growth hormone in its normal pulsatile pattern, rather than in one flat, continuous dose.
– Raises IGF-1 levels — Studies in healthy adults confirm measurable increases in IGF-1, the key growth signal downstream of growth hormone.
– Supports body composition research – Elevated growth hormone and IGF-1 are linked to reduced body fat and increased lean tissue in research models. Studied in ageing research Gerontology reviews identify this combination as relevant to age-related decline in growth hormone levels (somatopause) and muscle loss.
– Clean hormonal profile – Ipamorelin adds to growth hormone release without raising stress hormones such as cortisol, making it a precise research tool.
—
Quick Q&A
What is CJC-1295 + Ipamorelin blend used for in research?
It is studied as a dual-mechanism tool for stimulating growth hormone release and exploring how increased GH and IGF-1 affect body composition and ageing.
Is it approved for people?
No – it is sold for laboratory research only.
Important Notice
Sold for laboratory research only. Not for human use. Must be 18+.
More Information
A pre-blended combination of CJC-1295 (No DAC) and Ipamorelin — one of the most widely researched peptide combinations for studying the growth hormone secretagogue axis. CJC-1295 provides GHRH-receptor stimulation while Ipamorelin acts as a selective GHRP, together producing synergistic amplification of pulsatile GH release in preclinical models. For laboratory research use only.
